SCHEMBL9774513

SCHEMBL9774513

COC(=O)CC(C)N(C)C

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 12/20 0.42
▸ CHRNA4 P43681 12/20 0.42
▸ TSHR P16473 3/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CHRNB4 P30926 10/20 0.41
▸ CHRNA3 P32297 8/20 0.41
▸ HSD17B10 Q99714 1/20 0.39
▸ MGAM O43451 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ KCNA5 P22460 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23771196 0.77 MEN1 (0.39) CHRNB2CHRNA4TSHRMEN1KMT2A
SCHEMBL9774507 0.77 TSHR (0.39) CHRNB2CHRNA4TSHRMEN1KMT2A
SCHEMBL13623731 0.77 TSHR (0.39) CHRNB2CHRNA4TSHRMEN1KMT2A
SCHEMBL23771192 0.77 TSHR (0.50) CHRNB2CHRNA4TSHRMEN1KMT2A
SCHEMBL20028538 0.77 MGAM (0.46) CHRNB2CHRNA4TSHRCHRNB4CHRNA3
SCHEMBL5366870 0.77 KMT2A (0.53) TSHRMEN1KMT2AHSD17B10MGAM
SCHEMBL11619880 0.77 MGAM (0.37) CHRNB2CHRNA4TSHRMEN1KMT2A
Trimethylammonium SCHEMBL27917620 0.76 TSHR (0.42) TSHRMEN1KMT2AHSD17B10MGAM
SCHEMBL16327200 0.76 TSHR (0.37) TSHRMEN1KMT2AHSD17B10MGAM
Bromide SCHEMBL17746919 0.76 TSHR (0.48) CHRNB2CHRNA4TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183616-A1 NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME SENDA BIOSCIENCES, INC. (US) 2023-09-28 — — WO disclosed
US-7528140-B2 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors TEIJIN LIMITED (JP) 2009-05-05 — — US disclosed
US-4985556-A INTERMEDIATES AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1991-01-15 — — US disclosed
Send feedback